References
Referencesarepublicationsthatsupporttheproducts'biologicalactivity.
Zacharowskietal(2001)Ranolazine,apartialfattyacidoxidationinhibitor,reducesmyocardialinfarctsizeandcardiactroponinTreleaseintherat.Eur.J.Pharmacol.418105PMID:11334871
ShryockandBelardinelli(2008)Inhibitionoflatesodiumcurrenttoreduceelectricalandmechanicaldysfunctionofischaemicmyocardium.Br.J.Pharmacol.1531128PMID:18071302
Wangetal(2008)Antitorsadogeniceffectsof(+/-)-N-(2,6-dimethyl-phenyl)-4[2-hydroxy-3-(2-methoxyphenoxy)propyl]-1-piperazine(ranolazine)inanesthetizedrabbits.J.Pharmacol.Exp.Ther.325875PMID:18322148
Keywords:Ranolazinedihydrochloride,supplier,Anti-anginal,activates,pyruvate,dehydrogenase,anti-arrhythmic,agent,activators,Enzyme,Substrates,RS43285,RS,43285,Other,Dehydrogenases,Enzyme,Substrates,/,Activators,Miscellaneous,Compounds,Other,Dehydrogenases,TocrisBioscience